Business Models and Strategy


Market welcomes Attendo’s H1 figures as it turns the COVID corner

Attendo's H1 results saw improvement as COVID's impact lessened. And while the effects of the pandemic clearly have had a negative impact on the listed Nordic care group, the market reacted positively. A share price which at the start of July was down over 35% on it's mid-February price rallied, and it is now just 10% down compared to its pre-COVID position.

What does a good post-COVID outpatient clinic look like?

Outpatient activity all but came to a standstill as the COVID crisis tightened its grip. A panel of experts comprising Richard Banks, Chief Strategy Officer at international fertility player Virtus Health, Martin Bundschu, Director at Germany-based optical specialist Smile Eyes, former Colosseum Dental CEO Tomas Aubell, and L.E.K. Consulting's global co-head of healthcare Ben Faircloth joined an HBI-365 audience last week to discuss what a good outpatient clinic post-COVID might look like, and how markets have been affected.

Dentix Italia has 120 days to save the business

Spain's biggest dental chain, Dentix, has won a temporary reprieve from its creditors in Italy, but Dentix Italia must now come up with a recovery plan or find a buyer within the next three months.

Elderly care post-Covid: HBI Big Picture Seminar

How has Covid affected the elderly care sector across EMEA? To find out, HBI-365, the new global digital platform, brought together a panel of three: Fredrik Gren, CEO and president, Ambea, a sophisticated and large Pan-Scandinavian care group, Alexei Sidnev, CEO, Senior Group, the largest player in a big emerging market, Russia and Pierre-Emanuel Bercegeay, CEO, Ouihelp, a VC-backed, digital-savvy domiciliary homecare start-up in France. The seminar was followed by the first meeting of our HBI-365 elderly community with a useful roundtable on workforce.

Labs bounce back and eye opportunities

A v-shaped recovery, new markets, new customers, new entrants, new technology and the ear of big government: the HBI 2020 diagnostics panel discussion reveals new opportunities.

Major management reshuffle at Ping An Good Doctor

China's largest digital health platform Ping An Good Doctor is reportedly losing its CEO, COO, Chief Technology Officer, Chief Product Officer and Company Secretary. Is it trying to shift the platform into a more profitable B2B strategy?

Synlab raises €850m through bond

Pan-European lab group Synlab has issued over twice the amount of bond debt it was targeting in response to an low take-up of its bond-to-loan offer.

Interview: Dr Hugo Stephenson, CEO, Induction Healthcare

The Induction Switch app is used by the majority of hospital doctors in the UK but its owner has only very recently started generating revenue a year after launching on the AIM. That's despite a userbase stretching South Africa, Australia and the USA. Its CEO, an entrepreneur who has founded no less than three health tech companies, talks to HBI about how it plans to turn free-using customers into revenue-generating customers.

Find Us